Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Year: 2024
Drugmakers Sanofi and Sumitoma Pharma America (SMPA) each announced they are partially exempting Missouri-based providers from their contract pharmacy restrictions [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
340B INDUSTRY LEADER SPOTLIGHT
Christina Breckenridge, Senior Director of Client Success, RxStrategies
Q: Where did you grow up?
Kansas City, Missouri
Q: Where did you go to college/graduate school?
For undergraduate work, I went to school in Springfield, Missouri, at what was then Southwest Missouri State University and is now Missouri State University. I earned 2 graduate degrees in Kansas City, Missouri, at the University of Missouri-Kansas City.
Q:
…
Johnson & Johnson’s (J&J’s) proposed 340B rebate model, which has not received government approval, would give the drugmaker significantly more [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Missouri’s new law prohibiting drugmaker 340B contract pharmacy restrictions takes effect tomorrow, and the drug industry has responded with more [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Kedrion Biopharma has posted a refund notice to 340B providers, and Mylan notified covered entities of National Drug Code [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
If things were not difficult enough already for 340B providers, hospitals woke up on Friday morning to an announcement that [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
Apexus remarked in October 2023, “It’s no longer a question of whether you’ll be audited; it’s a matter of when.” In the present 340B program climate, this assertion could apply to more than just HRSA audits.
…
The federal agency that oversees the 340B program did not approve drugmaker Johnson & Johnson’s (J&J’s) proposal to convert certain [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In a move that would fundamentally alter the 340B program, pharmaceutical giant Johnson & Johnson (J&J) told hospitals this morning [...] …
